Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
16:58
2024 Guideline for the Management of Hypertrophic Cardiomyopathy
24:40
Hypertrophic Cardiomyopathy (HCM): Managing Symptoms
1:09:30
ACC Cardiology Hour From ESC Congress 2024
1:00:51
New Frontiers in Hypertrophic Cardiomyopathy: Cardiac Myosin Inhibitors
10:32
AHA 24: VALOR-HCM: Mavacamten in Patients with Obstructive HCM Referred for Septal Reduction Therapy
8:04
Canada will respond to Trump tariffs ‘like they’ve never seen before,’ says Ontario premier
2:21:29
Uzak Şehir 16. Bölüm
39:25